Response to Pederson et al. and Chlebowski et al.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to Pederson et al. and Chlebowski et al.

Published:2022-11-21 Issue:2 Volume:115 Page:229-230
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cold Søren¹^ORCID,Cold Frederik¹^ORCID,Jensen Maj-Britt²^ORCID,Cronin-Fenton Deirdre³^ORCID,Christiansen Peer⁴^ORCID,Ejlertsen Bent²⁵^ORCID

Affiliation:

1. Department of Oncology, Odense University Hospital , Odense, Denmark

2. Danish Breast Cancer Group, Rigshospitalet, Copenhagen University Hospital , Copenhagen, Denmark

3. Department of Clinical Epidemiology, Clinical Institute, Aarhus University and Aarhus University Hospital , Aarhus, Denmark

4. Department of Plastic and Breast Surgery, Aarhus University Hospital , Aarhus, Denmark

5. Department of Oncology, Rigshospitalet, Copenhagen University Hospital , Copenhagen, Denmark

Funder

Breast Friends

Danish Cancer Society

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djac214/47830885/djac214.pdf

Reference7 articles.

1. RE: systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study;Pederson;J Natl Cancer Inst,2022

2. RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study;Chlebowski;J Natl Cancer Inst,2022

3. PAM50 risk of recurrence score predicts 10-year distant recurrence in a comprehensive Danish cohort of postmenopausal women allocated to 5 years of endocrine therapy for hormone receptor-positive early breast cancer;Lænkholm;J Clin Oncol,2018

4. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2015

5. Danish breast cancer cooperative group;Christiansen;Clin Epidemiol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3